Key result
Genetically predicted body mass index demonstrated an inverted U-shaped causal association with serum IGF-1, increasing when BMI is <25 kg/m2 and decreasing when BMI exceeds 28 kg/m2.
Why the study?
The causal relationship between body mass index and insulin-like growth factor 1 remains debated in existing epidemiological studies.
Does body mass index causally affect serum insulin-like growth factor 1 levels in adults?
Observational (n=244,991)
Yes
Does body mass index causally affect serum insulin-like growth factor 1 levels in adults?
Answers are grounded in this paper and cite their sources.
This study provides genetic evidence for a non-linear, inverted U-shaped causal relationship between BMI and IGF-1, suggesting that IGF-1 increases with BMI in normal/thin individuals but decreases in overweight/obese individuals.
Objectives: Insulin-like growth factor1 (IGF-1) is a polypeptide hormone mainly secreted from the liver. The synthesis and secretion of IGF-1 are affected by various factors including unusual body weight. Nonetheless, the causal relationship between body mass index (BMI) and IGF-1 is still under debate from existing epidemiological studies, implying their complicated regulation pattern. Aiming to investigate their causal association, we conducted a large-scale linear and non-linear Mendelian randomization (MR) analysis in the UK Biobank (UKB) cohort with BMI as the exposure and IGF-1 as the outcome. Methods: After applying a series of exclusion criteria and covariate adjustment, a total of 244 991 participants from the UKB were eligible for analysis. The polygenic risk score (PRS) of BMI was constructed on 96 instrumental variables (IVs). The non-linear observational association between BMI and IGF-1 was examined by a restricted cubic spline test. Non-linear MR analysis was performed with the piecewise linear method and verified by doubly-ranked stratification and log-transformation methods. In addition to combined analysis, stratified analysis was performed by sex and age groups. A series of sensitivity analyses were performed to examine the robustness of the results. Results: Restricted cubic spline regression demonstrated an inverted U-shaped association between BMI and IGF-1 (P non-linear<0.001), which was also supported by MR analysis (Quadratic P-value: 4.93×10-6, Cochran Q P-value: 2.94×10-5). Specifically, genetically predicted BMI was significantly positively correlated with IGF-1 levels when BMI was less than 25kg/m2, and genetically predicted BMI was significantly negatively correlated with IGF-1 levels when BMI exceeded around 28kg/m2. Stratified analysis showed no difference against sex and different age groups. Sensitivity analyses gave similar results, demonstrating the robustness of the results. Conclusions: This study suggested a non-linear causal relationship between BMI and IGF-1 and this effect may not influenced by sex and age.
No takes yet. Share an insight, caveat, or question.
Pei et al. (2023) reported an observational. Body mass index was evaluated on Serum insulin-like growth factor 1 (IGF-1) concentration (p=4.93x10-6 for quadratic test). Genetically predicted body mass index demonstrated an inverted U-shaped causal association with serum IGF-1, increasing when BMI is <25 kg/m2 and decreasing when BMI exceeds 28 kg/m2.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: